Insights on clinical outcomes in according to age in patients undergoing Transcatheter Aortic Valve Replacement

Abstract   Transcatheter Aortic Valve Replacement (TAVR) is considered the treatment in patients older or at high or intermediate risk. Results form contemporary randomized trials in low-risk patients will likely broaden the indication of TAVR, but the data regarding long-term are limited by older p...

Full description

Saved in:
Bibliographic Details
Published in:European heart journal 2021-10, Vol.42 (Supplement_1)
Main Authors: Munoz-Garcia, M, Munoz-Garcia, E, Munoz Garcia, A J, Dominguez-Franco, A J, Alonso-Briales, J H, Jimenez-Navarro, M F, Hernandez-Garcia, J M, Gomez-Doblas, J J
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract   Transcatheter Aortic Valve Replacement (TAVR) is considered the treatment in patients older or at high or intermediate risk. Results form contemporary randomized trials in low-risk patients will likely broaden the indication of TAVR, but the data regarding long-term are limited by older population. The aim of this study was to evaluate the survival and the factors predicting mortality after TAVR in according to age. Methods From April 2008 to December 2019, the self-expandable and balloon-expandable prostheses were was implanted in 765 patients with symptomatic severe aortic stenosis with deemed high risk on base to age,
ISSN:0195-668X
1522-9645
DOI:10.1093/eurheartj/ehab724.2814